Manufacture

Defining the best strategies for working with highly potent drug substances.

Embracing the benefits of auto-injectors.

What milestones will define the next era in the mRNA story?

Welcome to our Special Series E-book on Advanced Medicine!

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.

Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

What are the challenges and best practices in quality control for difficult-to-inspect products?

Has pharma fully acknowledged the power of rapid-dissolve tablet technologies?

Precious metals-bearing catalysts are essential in some pharma processes – but, once they’re spent, they still hold value.

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.